That's it I'm afraid for the next two years. The next announcement of note will be in late 2008 (Phase IIb HIV results). Nothing much until then - in large part due to management not having the brains to raise enough money to continue the development of two of their three products.
Get out now and buy back in two years time. Who knows, maybe the price will hit $0.20 then, which would be no mean feat, given the company will have 300 million shares on issue by then.
It's pity that management has never got the message that junior biotechs need a newsflow.
Add to My Watchlist
What is My Watchlist?
